Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil Consumer Healthcare

This article was originally published in The Tan Sheet

Executive Summary

Tylenol and Motrin marketer plans to launch an ad campaign in early 2001 for newly acquired St. Joseph aspirin brand, targeting older patients seeking low dose therapy and highlighting the product's "cardio-protective" benefits. McNeil announced it had acquired the business from Schering-Plough Healthcare Products for an undisclosed amount Dec. 19. Manufacturing of the Chattanooga-based firm's product will be consolidated into McNeil's facilities. The orange-flavored 81 mg aspirin tablets will join McNeil's rapidly expanding analgesic portfolio, which added products indicated for migraine and menstrual pain in 2000. St. Joseph was heavily promoted in the 1950s and 1960s, but has not had active advertising since the 1980s, McNeil says
Advertisement

Related Content

St. Joseph Aspirin Marketing Stresses Physician Involvement
St. Joseph Aspirin Marketing Stresses Physician Involvement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092039

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel